KR101782671B1 - 피부 질환을 치료하는 방법 - Google Patents

피부 질환을 치료하는 방법 Download PDF

Info

Publication number
KR101782671B1
KR101782671B1 KR1020137025194A KR20137025194A KR101782671B1 KR 101782671 B1 KR101782671 B1 KR 101782671B1 KR 1020137025194 A KR1020137025194 A KR 1020137025194A KR 20137025194 A KR20137025194 A KR 20137025194A KR 101782671 B1 KR101782671 B1 KR 101782671B1
Authority
KR
South Korea
Prior art keywords
skin
year
delete delete
zep3
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137025194A
Other languages
English (en)
Korean (ko)
Other versions
KR20140027122A (ko
Inventor
나프탈리 프리모
Original Assignee
에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드 filed Critical 에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드
Publication of KR20140027122A publication Critical patent/KR20140027122A/ko
Application granted granted Critical
Publication of KR101782671B1 publication Critical patent/KR101782671B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020137025194A 2011-03-28 2012-03-25 피부 질환을 치료하는 방법 Active KR101782671B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161468212P 2011-03-28 2011-03-28
US61/468,212 2011-03-28
PCT/IL2012/050105 WO2012131676A1 (en) 2011-03-28 2012-03-25 Method for treating disorders of the skin

Publications (2)

Publication Number Publication Date
KR20140027122A KR20140027122A (ko) 2014-03-06
KR101782671B1 true KR101782671B1 (ko) 2017-09-27

Family

ID=46052836

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137025194A Active KR101782671B1 (ko) 2011-03-28 2012-03-25 피부 질환을 치료하는 방법

Country Status (18)

Country Link
US (1) US9012397B2 (https=)
EP (1) EP2691103B1 (https=)
JP (1) JP5872673B2 (https=)
KR (1) KR101782671B1 (https=)
CN (1) CN103458912B (https=)
AU (1) AU2012235632B2 (https=)
BR (1) BR112013023537B1 (https=)
CA (1) CA2830135C (https=)
DK (1) DK2691103T3 (https=)
ES (1) ES2598829T3 (https=)
HR (1) HRP20161006T1 (https=)
HU (1) HUE030152T2 (https=)
IL (1) IL228292A (https=)
MX (1) MX2013011219A (https=)
PL (1) PL2691103T3 (https=)
PT (1) PT2691103T (https=)
RU (1) RU2583137C2 (https=)
WO (1) WO2012131676A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016116948A1 (en) 2015-01-22 2016-07-28 Ram Isanaka Peptide for treating inflammatory diseases
BR102017010169A2 (pt) * 2017-05-15 2019-02-26 Remer Consultores Assessoria Empresarial Ltda. composto, intermediário de síntese, uso na preparação de anticonvulsivante, composição farmacêutica anticonvulsivante
SG11202009257TA (en) * 2018-03-29 2020-10-29 S I S Shulov Innovative Science Ltd Pharmaceutical compositions for inhibiting inflammatory cytokines
EP4034147A4 (en) * 2019-09-26 2023-10-18 S.I.S. Shulov Innovative Science Ltd. COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE, AGE-RELATED AND TRAUMA-INDUCED DISORDERS
AU2020356605A1 (en) 2019-09-26 2022-04-14 S.I.S. Shulov Innovative Science Ltd. Anti-aging compositions and methods of use thereof
KR102911055B1 (ko) * 2023-05-16 2026-01-09 황현호 구리원사를 적용한 원단을 사용한 섬유제품

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619916A (en) 1983-12-23 1986-10-28 Polifarma S.P.A. Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications
WO2002012269A2 (en) 2000-08-10 2002-02-14 S.I.S Shulov Institute For Science Ltd. Pharmaceutical composition comprising an analgesic peptide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237474B (it) * 1989-10-05 1993-06-07 Polifarma Spa Composti tripeptidici e loro uso farmaceutico come immuno-modulatori
WO1992019254A1 (en) 1991-04-24 1992-11-12 Warner-Lambert Company α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
IL123001A (en) 1998-01-20 1998-12-06 Shulov Inst For Venom Research Analgesic fraction from snake March and pharmacy preparations containing it
WO2001001748A2 (en) * 1999-07-02 2001-01-11 Genentech, Inc. Peptide compounds that bind her2
AU767940B2 (en) * 1999-07-14 2003-11-27 S.I.S Shulov Institute For Science Ltd. Analgesic from snake venom
AU2002307369A1 (en) * 2001-04-13 2002-10-28 Genome Therapeutics Corporation Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
CN101048170B (zh) * 2004-05-06 2011-04-13 生物合成实验室有限公司 源自响尾蛇crotalus durissus terrificus蛇毒的止痛肽的类似化合物、它们的用途、组合物、 制备和纯化方法
CN101058572A (zh) * 2007-03-13 2007-10-24 中国药科大学 一种新的具有抗肿瘤活性的肽类化合物
CN101239178A (zh) * 2008-03-13 2008-08-13 中国药科大学 一种肽类化合物的抗血栓用途
US8518399B2 (en) * 2010-11-17 2013-08-27 Tamir Biotechnology, Inc. Methods of treating infections originating from viruses in the herpesviridae family

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619916A (en) 1983-12-23 1986-10-28 Polifarma S.P.A. Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications
WO2002012269A2 (en) 2000-08-10 2002-02-14 S.I.S Shulov Institute For Science Ltd. Pharmaceutical composition comprising an analgesic peptide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Pharmacy and Pharmacology. Vol. 61, No. 1, pp. 89-94 (2009)

Also Published As

Publication number Publication date
EP2691103A1 (en) 2014-02-05
CN103458912A (zh) 2013-12-18
US9012397B2 (en) 2015-04-21
WO2012131676A4 (en) 2012-11-22
ES2598829T3 (es) 2017-01-30
PT2691103T (pt) 2016-10-25
JP5872673B2 (ja) 2016-03-01
CA2830135C (en) 2019-12-17
EP2691103B1 (en) 2016-07-20
RU2583137C2 (ru) 2016-05-10
CN103458912B (zh) 2016-01-20
US20130310309A1 (en) 2013-11-21
HK1186986A1 (zh) 2014-03-28
AU2012235632A1 (en) 2013-09-26
KR20140027122A (ko) 2014-03-06
JP2014510748A (ja) 2014-05-01
HRP20161006T1 (hr) 2016-10-21
PL2691103T3 (pl) 2016-12-30
AU2012235632B2 (en) 2015-12-03
BR112013023537B1 (pt) 2022-05-31
WO2012131676A1 (en) 2012-10-04
IL228292A (en) 2017-05-29
HUE030152T2 (en) 2017-04-28
CA2830135A1 (en) 2012-10-04
MX2013011219A (es) 2013-10-17
DK2691103T3 (en) 2016-11-21
BR112013023537A2 (pt) 2016-12-06
RU2013143041A (ru) 2015-03-27

Similar Documents

Publication Publication Date Title
KR101782671B1 (ko) 피부 질환을 치료하는 방법
US3549770A (en) Therapeutic administration of effective amounts of dimethyl sulfoxide to human and animal subjects
JPH07503456A (ja) 医薬的ジペプチド組成物およびその使用法
HUE033499T2 (en) Use of combination antimicrobials
ES2221176T3 (es) Uso de glucosamina y derivados de glucosamina para el alivio rapido del picor o dolor localizado.
AU668088B2 (en) Pharmaceutical dipeptide compositions and methods of use thereof
WO2002014343A8 (en) Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents
JP2014510748A5 (https=)
EP1309613B1 (en) Pharmaceutical composition comprising an analgesic peptide
JPH039885B2 (https=)
KR20260030114A (ko) 신규한 다기능성 올리고펩타이드
HK1186986B (en) Method for treating disorders of the skin
RU2338553C2 (ru) Средство для наружного применения, обладающее противовирусной активностью
US3171782A (en) Oral compositions comprising lysozyme and vitamin b6
CN116509831B (zh) 含有藏红花酸或其可药用盐的外用制剂的用途
RU2147440C1 (ru) Обезболивающее и противозудное средство
JPS6045161B2 (ja) 熱傷の治療剤
US20190000822A1 (en) Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis
US20060057133A1 (en) Topical pathogenic-tissue-destroying liquid
CN117243948A (zh) 包含瑞香素的组合物在制备风湿性关节炎药物中的应用
RU2290188C2 (ru) Способ лечения воспалительных и реактивно-дистрофических заболеваний больших слюнных желез
CN118436762A (zh) 替考拉宁在制备治疗雄激素性脱发药物中的应用
CN118649226A (zh) 重组贻贝粘蛋白在制备缓解口腔创面疼痛产品中应用
JPS58164511A (ja) 老人性▲そう▼痒症の治療剤
JP2001163782A (ja) 皮膚疾患治療用外用剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
A302 Request for accelerated examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20200914

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20210907

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20220905

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 9